Stephen F. Vobach, M.D..
NPI 1851377006ActiveIndividual· Psychiatry & Neurology, Psychiatry· Dallas, TX
Opted out of Medicare from July 2024 to July 2028. Psychiatry & Neurology, Psychiatry (M.D..) in Dallas, Texas, licensed in TX, with an NPI issued in December 2005. Their prescriptions cost Medicare Part D more than their services did: $646,550 for 6,765 claims, against $52,604 paid for services in 2024. Vanda Pharmaceuticals Inc. was the largest of 21 companies reporting payments in 2025, $49,701 in all, mostly speaking and faculty fees.
Overview
| NPI | 1851377006 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D.. |
| Sole proprietor | Yes |
| NPI issued | Dec 20, 2005 |
| Last updated in NPPES | Jul 6, 2018 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Psychiatry & Neurology, Psychiatry Primary | 2084P0800X | H8489 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jul 1, 2024 – Jul 1, 2028 |
| Can order and refer | No |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 289 |
|---|---|
| Services billed | 794 across 6 procedure codes |
| Paid by Medicare | $52,604 |
Part D prescriptions in 2024
| Prescriptions (claims) | 6,765 · 10,563 30-day fills |
|---|---|
| Patients | 572 |
| Total drug cost | $646,550 |
| Generic share | 92% of claims |
Industry payments (Open Payments)
- 2025$49,701 · 279 payments from 21 companies
- 2024$40,038 · 266 payments from 21 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Vanda Pharmaceuticals Inc. | $25,517 | 51 |
| Abbvie Inc. | $21,040 | 46 |
| Otsuka America Pharmaceutical, Inc. | $469.18 | 24 |
| Neurocrine Biosciences, Inc. | $459.15 | 27 |
| Axsome Therapeutics, Inc. | $434.71 | 22 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$43,560 · 18 payments
- Food and Beverage$4,670 · 241 payments
- Travel and Lodging$1,472 · 20 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Psychiatry & Neurology, Psychiatry providers in Dallas
- 1144146713
- 1316914666
- 1639769490
- 1134503873
- 1588251854
- 1750562237
- 1740081595
- 1912032319
- 1225866114
- 1164948097
- 1700651775
- 1407328594